Publications by authors named "Jean-Pierre Mach"

Claim this Profile
C
Correction to: CART cells are prone to Fas- and DR5-mediated cell death.
Benjamin O Tschumi, Nina Dumauthioz, Bastien Marti, Lianjun Zhang, Evripidis Lanitis, Jean-Pierre Mach

J Immunother Cancer· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of cytokine immune response profile in response to inflammatory stimuli in mice with genetic defects in fetal and adult hemoglobin chain expression.
Ismat Khatri, Christian Alexander, Klaus Brandenburg, Zhiqi Chen, Adrian Heini, Jean-Pierre Mach

Pharmacogenomics J· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CART cells are prone to Fas- and DR5-mediated cell death.
Benjamin O Tschumi, Nina Dumauthioz, Bastien Marti, Lianjun Zhang, Evripidis Lanitis, Jean-Pierre Mach

J Immunother Cancer· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing actions of peptides derived from the γ-chain of fetal human hemoglobin on the immunostimulant activities of monophosphoryl lipid A.
Artur J Ulmer, Yani Kaconis, Lena Heinbockel, Wilmar Correa, Christian Alexander, Jean-Pierre Mach

Innate Immun· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Validation of a Novel Generic Platform for the Production of Tetravalent IgG1-like Bispecific Antibodies.
Josée Golay, Sylvie Choblet, Justyna Iwaszkiewicz, Pierre Cérutti, Annick Ozil, Jean-Pierre Mach

J Immunol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mammalian Target of Rapamycin Complex 2 Controls CD8 T Cell Memory Differentiation in a Foxo1-Dependent Manner.
Lianjun Zhang, Benjamin O Tschumi, Isabel C Lopez-Mejia, Susanne G Oberle, Marten Meyer, Jean-Pierre Mach

Cell Rep· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classification of current anticancer immunotherapies.
Lorenzo Galluzzi, Erika Vacchelli, José-Manuel Bravo-San Pedro, Aitziber Buqué, Laura Senovilla, Jean-Pierre Mach

Oncotarget· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
iNKT/CD1d-antitumor immunotherapy significantly increases the efficacy of therapeutic CpG/peptide-based cancer vaccine.
Stéphanie Corgnac, Rachel Perret, Lianjun Zhang, Jean-Pierre Mach, Pedro Romero

J Immunother Cancer· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radioimmunotherapy combined with maintenance anti-CD20 antibody may trigger long-term protective T cell immunity in follicular lymphoma patients.
Franz Buchegger, Steven M Larson, Jean-Pierre Mach, Yves Chalandon, Pierre-Yves Dietrich

Clin Dev Immunol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mammalian target of rapamycin complex 1 orchestrates invariant NKT cell differentiation and effector function.
Lianjun Zhang, Benjamin O Tschumi, Stéphanie Corgnac, Markus A Rüegg, Michael N Hall, Jean-Pierre Mach

J Immunol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In memory of Garry Abelev 1928-2013.
Natasha Engelhardt, Jean-Pierre Mach

Tumour Biol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction to monoclonal antibodies.
Jean-Pierre Mach

Cancer Immun· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses.
Stéphanie Corgnac, Rachel Perret, Laurent Derré, Lianjun Zhang, Kathrin Stirnemann, Jean-Pierre Mach

Cancer Immunol Immunother· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In pancreatic carcinoma, dual EGFR/HER2 targeting with cetuximab/trastuzumab is more effective than treatment with trastuzumab/erlotinib or lapatinib alone: implication of receptors' down-regulation and dimers' disruption.
Christel Larbouret, Nadège Gaborit, Thierry Chardès, Mickaël Coelho, Emmanuelle Campigna, Jean-Pierre Mach

Neoplasia· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumour effects of single or combined monoclonal antibodies directed against membrane antigens expressed by human B cells leukaemia.
Séverine Loisel, Pierre-Alain André, Josee Golay, Franz Buchegger, Jean Kadouche, Jean-Pierre Mach

Mol Cancer· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Possible misinterpretation of the mode of action of therapeutic antibodies in vitro: homotypic adhesion and flow cytometry result in artefactual direct cell death.
Josée Golay, Luca Bologna, Pierre-Alain André, Franz Buchegger, Jean Pierre Mach

Blood· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An infrared reflection-absorption spectroscopic (IRRAS) study of the interaction of lipid A and lipopolysaccharide Re with endotoxin-binding proteins.
Andreas Kerth, Patrick Garidel, Jörg Howe, Christian Alexander, Jean-Pierre Mach

Med Chem· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Redirecting NK cells mediated tumor cell lysis by a new recombinant bifunctional protein.
Claire Germain, Emmanuelle Campigna, Imed Salhi, Sébastien Morisseau, Isabelle Navarro-Teulon, Jean-Pierre Mach

Protein Eng Des Sel· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemoglobin enhances the biological activity of synthetic and natural bacterial (endotoxic) virulence factors: a general principle.
Jörg Howe, Walter Richter, Lynn Hawkins, Manfred Rössle, Christian Alexander, Jean Pierre Mach

Med Chem· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant radioimmunotherapy trial with iodine-131-labeled anti-carcinoembryonic antigen monoclonal antibody F6 F(ab')2 after resection of liver metastases from colorectal cancer.
Marc Ychou, David Azria, Cathy Menkarios, Patrick Faurous, François Quenet, Jean-Pierre Mach

Clin Cancer Res· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained activation and tumor targeting of NKT cells using a CD1d-anti-HER2-scFv fusion protein induce antitumor effects in mice.
Kathrin Stirnemann, Jackeline F Romero, Lucia Baldi, Bruno Robert, Valérie Cesson, Jean-Pierre Mach

J Clin Invest· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural investigations into the interaction of hemoglobin and part structures with bacterial endotoxins.
Jörg Howe, Patrick Garidel, Manfred Roessle, Walter Richter, Christian Alexander, Jean Pierre Mach

Innate Immun· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo therapeutic synergism of anti-epidermal growth factor receptor and anti-HER2 monoclonal antibodies against pancreatic carcinomas.
Christel Larbouret, Bruno Robert, Isabelle Navarro-Teulon, Simon Thèzenas, Maha-Zohra Ladjemi, Jean-Pierre Mach

Clin Cancer Res· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biophysical characterization of the interaction of endotoxins with hemoglobins.
Jörg Howe, Malte Hammer, Christian Alexander, Manfred Rössle, Karin Fournier, Jean-Pierre Mach

Med Chem· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates.
Valérie Cesson, Kathrin Stirnemann, Bruno Robert, Immanuel Luescher, Thomas Filleron, Jean-Pierre Mach

Clin Cancer Res· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis